Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
收藏DataMed2026-07-14 收录
官方服务：
资源简介：
Patients will receive budesonide or placebo for the treatment of active lymphocytic colitis. This study includes stool collections, blood draws, weekly questionnaires and a sigmoidoscopy. The study hypothesis is that budesonide will be safe and effective compared with placebo for the treatment of diarrhea in lymphocytic colitis.
提供机构：
ClinicalTrials.gov
